GGrantIndex
← Leaderboards

Alyssa Ione Clay-Gilmour

Roswell Park Cancer Institute Corp

$1,711,362
Attributed
$5,805,349
Total exposure
2
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY202125
$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$5,805,349 · 2

By mechanism

R01$3,120,296 · 1
U01$2,685,053 · 1

Top collaborators

Most similar at Roswell Park Cancer Institute Corp

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Etiology

Research focus

EtiologyGeneticVariantValidationPolygenic Risk ScoreGenetic StudyGenotypeGenome Wide Association StudyPredispositionUnited States National Institutes Of HealthResourcesClinical PracticeCollaborationsGenetic VariantEuropeanBiobankBindingAmericanB Cell ProliferationBayesian MethodAllogenicAffectCodeAutoimmune Diseases

Grant awards (10)

Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation$605,569
R01 · FY2025 · CA
InterLymph Consortium: interrogating pleiotropy and gene by environment interactions among hematopoietic malignancies.$544,532
U01 · FY2025 · CA
Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation$593,753
R01 · FY2024 · CA
InterLymph Consortium: interrogating pleiotropy and gene by environment interactions among hematopoietic malignancies.$510,942
U01 · FY2024 · CA
InterLymph Consortium: interrogating pleiotropy and gene by environment interactions among hematopoietic malignancies.$529,273
U01 · FY2023 · CA
Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation$503,068
R01 · FY2023 · CA
InterLymph Consortium: interrogating pleiotropy and gene by environment interactions among hematopoietic malignancies.$529,422
U01 · FY2022 · CA
Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation$463,641
R01 · FY2022 · CA
Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation$954,265
R01 · FY2021 · CA
InterLymph Consortium: interrogating pleiotropy and gene by environment interactions among hematopoietic malignancies.$570,884
U01 · FY2021 · CA